RedShift BioAnalytics

United States
Prairie City, Iowa, United States, 01803

Company profile

RedShift BioAnalytics company profile

RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind. The company was founded in 2005 and is headquartered in Burlington, Massachusetts.

Business identity

Contact email
[email protected]
Phone number
781.345.7300
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2005-01-01, Year

Headquarters

Postal code
01803
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
9
Total equity funding
$76.7M
Last funding
Series Unknown / $5.9M / 2025-06-25
Last equity funding
Series Unknown / $5.9M
Investors
8
Lead investors
4
Founders
4
Articles
14

Founders and investors

Founders

Chip MarshallEugene MaMatthias WagnerStuart Nixdorff

Lead investors

Illumina VenturesInterWest PartnersTechnology Venture PartnersWaters

Investors

Alta PartnersIllumina VenturesInterWest PartnersTechnology Venture PartnersWaters